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Objectives. The purpose of this study was to examine whether
P wave signal-averaged electrocardiogram (P-SAECG), which
detects subtle changes in P wave, detects the concealed accessory
atrioventricular pathway (AP).
Background. It is difficult to differentiate atrioventricular re-
ciprocating tachycardia (AVRT) due to the AP from atrioventric-
ular nodal reentrant tachycardia (AVNRT) when the ventricular
preexcitation is absent on 12-lead electrocardiograms. By electro-
physiological studies, the anterograde conduction in the concealed
AP is shown to be blocked near the AP-ventricular interface
during sinus rhythm.
Methods. P-SAECG during sinus rhythm was performed in 20
normal volunteers (control), 21 patients with AVRT due to the
concealed AP, 19 with AVNRT, 22 with paroxysmal atrial
fibrillation (PAF), and 7 with automatic atrial tachycardia
(AT). The filtered P wave duration (FPD) and AR20 (power
spectrum area ratio of 0 –20 to 20 –100 Hz) were measured and
repeated in AVRT, AVNRT and AT groups at one week after
catheter ablation.
Results. The anterograde conduction in the concealed left-sided
AP was confirmed in all cases by an electrophysiological study. The
FPD in AVRT group was more prolonged than that in controls or
AVNRT group. Although the FPD was similar between AVRT and
PAF groups, AR20 differentiated between the two groups. Ablation of
the concealed AP shortened FPD in AVRT group but that of the slow
pathway or the atrial focus did not shorten in the AVNRT or AT
groups, respectively. The changes in FPD after ablation were corre-
lated with those in the duration of atrial activity by an electrophys-
iological study (r 5 0.67).
Conclusions. Our findings suggest that P-SAECG detects the
concealed left-sided AP, providing a clinical tool in noninvasively
assessing atrial activation patterns.
(J Am Coll Cardiol 1999;33:55–62)
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The common form of paroxysmal supraventricular tachycardia
is either atrioventricular reciprocating tachycardia (AVRT)
due to the accessory atrioventricular pathway (AP) or atrio-
ventricular nodal reentrant tachycardia (AVNRT) due to dual
atrioventricular nodal pathways (1–5). It is clinically important
to diagnose whether paroxysmal supraventricular tachycardia
is due to the conduction through a reentrant circuit comprising
either the AP or dual atrioventricular nodal pathways because
of the differences in therapeutic strategies (4,6–10). However,
when the ventricular preexcitation through the AP is absent on
standard electrocardiograms, it is difficult to noninvasively
detect the AP during sinus rhythm.
In the previous anatomical studies, most APs have been
shown to course through the subepicardial fat pad around the
mitral annulus and to connect the epicardial surface of the left
atrium to that of the left ventricle (11–14). The AP through
which impulses conduct only in the retrograde direction is
generally called the concealed AP (7,15). Recently, electro-
physiological studies have demonstrated that anterograde con-
duction in the concealed AP is present and blocked at or near
the AP-ventricular interface during sinus rhythm (16–22),
suggesting that an atrial impulse conducts until the AP-
ventricular interfaces through the concealed AP.
The P wave signal-averaged electrocardiogram (P-SAECG)
has been clinically applied to atrial arrhythmias. The
P-SAECG can detect the subtle abnormalities of intraatrial
conduction. Recent clinical studies by others (23–26) and us
(27) demonstrated a prolonged filtered P wave duration (FPD)
by the time domain analysis in patients with a paroxysmal atrial
fibrillation (PAF). Therefore, we hypothesized that in patients
with the concealed AP, the activation potential of anterograde
conduction in the concealed AP may prolong the terminal
section of atrial activation, which may prolong FPD obtained
by the P-SAECG. Accordingly, the purpose of the present
study was to test whether P-SAECG is useful to detect the
presence of the concealed AP in patients with a history of
supraventricular tachycardia with narrow QRS configurations.
Methods
Study subjects. Eighty-nine subjects were enrolled in this
study (Table 1). No patients had any evidence of ventricular
From the Department of Internal Medicine III and The Cardiovascular
Research Institute, Kurume University School of Medicine, 67 Asahi-machi,
Kurume, 830-0011 Japan.
Manuscript received December 23, 1997; revised manuscript received July
16, 1998, accepted September 17, 1998.
Address for correspondence: Dr. Tatsuro Hiraki, The Department of
Internal Medicine III, Kurume University School of Medicine, 67 Asahi-machi,
Kurume, 830-0011 Japan.
JACC Vol. 33, No. 1
January 1999:55–62
55
©1998 by the American College of Cardiology 0735-1097/99/$20.00
Published by Elsevier Science Inc. PII S0735-1097(98)00525-7
preexcitation (delta wave) on 12-lead standard electrocardio-
gram and Holter monitoring. Twenty-one patients had docu-
mented AVRT with the concealed AP and without a PAF.
They were 16 to 72 years old. Nineteen patients had docu-
mented AVNRT with dual atrioventricular nodal pathways
and without a PAF. They were 15 to 67 years old. Twenty-two
patients had documented symptomatic PAF. They were 40 to
60 years old. Seven patients had documented symptomatic
automatic atrial tachycardia (AT). They were 20 to 59 years
old. Twenty healthy volunteers, who were matched with the
other four study groups for age and sex, served as a control
group. They were 26 to 60 years old. No subjects had coexistent
organic heart diseases as assessed by two dimensional echo-
cardiography and cardiac catheterization. Clinical characteris-
tics were similar among the five groups for the sex distribution,
age, cardiothoracic ratio on chest x-rays, and dimension of
cardiac chambers and ejection fraction measured by echocar-
diography. All antiarrhythmic agents were discontinued $5
half-lives before the study. Written informed consent was
obtained from all subjects. This study was approved by the
ethical committee of human investigations in our institution.
P-SAECG. According to the previous method (27), record-
ings were made in a shielded room to minimize noise. For the
P-SAECG recording, we used a multi-purpose electrocardio-
graph (VCM-3000, Fukuda Denshi Co., Tokyo, Japan) and a
micro-potential preamplifier (VL-303, Fukuda Denshi Co.,
Tokyo, Japan). Ag/AgCl electrodes were placed on the chest of
each resting subject who lay on the back. The signal-averaged
electrocardiogram was recorded from a modified X, Y, and Z
lead system, which was developed for P wave signal averaging
as well as for conventional R wave-triggered signal averaging
(28). The X lead was between the right and left shoulders,
similar to the standard I lead. The aVF lead was used as the Y
lead. The Z lead was positioned on the precordial center line
in the fifth intercostal space. For the recording, we amplified by
1000 times the potential signals derived through these X, Y
and Z leads. Input signals were sampled at 1 kHz and A/D
converted in 12 bits. All signal data were identified by the
P wave template-matching method. P wave-triggered signals of
250 beats during sinus rhythm, excluding supraventricular
premature contractions, were integrated without filtering
(23,27). After the 250 beats integration, the noise level was
lower than 1 mV. The acquired data were stored on a floppy
disk and analyzed using a personal computer (PC-9821, NEC
Co., Tokyo, Japan).
Time and frequency domain analysis. For time domain
analysis, averaged P wave triggered signals were filtered
through a band-pass filter of 40–300 Hz with use of a Butter-
worth filter according to the conventional method (23,27). A
spatial vector magnitude electrocardiogram was compiled with
X, Y, and Z leads (23,27). With the use of a computer graphic
cursor, the onset and offset of P wave were defined as the point
at which the voltage of the atrial signal exceeded 1 mV in the
TP segment and returned to the 1 mV level, respectively (27).
With this method, we were able to measure changes of the
P wave by 1 ms. A representative recording is shown in Fig. 1A.
For frequency domain analysis, the method of processing was
designed to give a power spectrum of the whole P wave. The
start and end points of P wave obtained from signal-averaging
were identified with the use of a computer graphic cursor on
the basis of the standard electrocardiographic criteria as
previously described by us (27). Fast Fourier Transform anal-
ysis with Blackmann–Harris four-term window (29) was per-
formed in the lead Z. As shown in Fig. 1B, AR20 (i.e., the
power spectrum area in the 0–20 Hz zone divided by that in the
20–100 Hz zone) was calculated. The FPD and AR20 were
measured in all subjects and repeated in AVRT and AVNRT
groups at one week after radiofrequency catheter ablation. To
assess the effect of atrial ablation on the P-SAECG, the FPD
and AR20 were also measured in patients with AT without
accessory pathway before, and one week after, catheter abla-
tion.
Electrophysiological study. In 58 patients with a docu-
mented paroxysmal supraventricular tachycardia without ap-
parent ventricular preexcitation on standard electrocardio-
grams, an electrophysiological study was performed with local
anesthesia. Briefly, three 6F quadripolar electrode catheters
(RESPONSE, Daig Co., Minnetonka, Minnesota) were ad-
vanced to the high right atrium, his bundle, and right ventric-
ular apex. A 6F octpolar electrode catheter (RESPONSE,
Daig Co., Minnetonka, Minnesota) was advanced to the cor-
onary sinus. Sustained supraventricular tachycardia was in-
duced by programmed stimulation and the presence of mech-
anisms with AVRT or AVNRT was defined by standard
Abbreviations and Acronyms
AP 5 accessory atrioventricular pathway
AVNRT 5 atrioventricular nodal reentrant tachycardia
AVRT 5 atrioventricular reciprocating tachycardia
AT 5 atrial tachycardia
FPD 5 filtered P wave duration
PAF 5 paroxysmal atrial fibrillation
P-SAECG 5 P wave signal-averaged electrocardiogram
Table 1. Clinical Characteristics of Study Subjects
Control
(n 5 20)
AVNRT
(n 5 19)
AVRT
(n 5 21)
PAF
(n 5 22)
AT
(n 5 7)
Male/female 13/7 7/12 14/7 16/6 4/3
Age (yr) 42 6 9 49 6 17 45 6 17 49 6 7 39 6 16
CTR (%) 45 6 5 46 6 4 46 6 5 46 6 5 47 6 4
LAD (mm) 32 6 5 31 6 3 33 6 5 35 6 5 33 6 6
LVDd (mm) 45 6 5 47 6 5 47 6 5 48 6 6 48 6 4
LVDs (mm) 28 6 4 31 6 5 30 6 3 32 6 6 32 6 4
EF (%) 74 6 8 72 6 7 73 6 7 71 6 7 67 6 8
Data are presented mean value 6 SD or number of patients. AVNRT 5
atrioventricular nodal reentrant tachycardia; AT 5 atrial tachycardia; PAF 5
paroxysmal atrial fibrillation; AVRT 5 atrioventricular reciprocating tachycar-
dia; CTR 5 cardiothoracic ratio; LAD 5 left atrial dimension; LVDd 5 left
ventricular end-diastolic dimension; LVDs 5 left ventricular end-systolic dimen-
sion; EF 5 ejection fraction.
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techniques (10,30,31). In this study, 34 patients had AVRT
(right-sided AP in 2 and left-sided AP in 32) and the remaining
24 did AVNRT. In these patients with AVRT or AVNRT, we
excluded patients with a history of PAF from this study. As a
result, 25 patients had AVRT (left-sided AP in all) and 23 had
AVNRT. Furthermore, we confirmed that patients with
AVRT did not have latent preexcitation by coronary sinus
pacing near the accessory pathway or administration of intra-
venous injection of adenosine (20 mg, one bolus) (32). Next,
programmed electrical stimulation using eight basic stimuli
(S1) at a cycle length of 600 ms followed by single extrastimulus
(S2) was delivered at the high right atrium. The S1S2 interval
was shortened by 10 ms until it reached the effective refractory
period of the right atrium. A1 and A2 referred to the atrial
activity resulting from S1 and S2, respectively. To exclude
patients with a substrate for PAF, which affects the P-SAECG,
the following exclusion criteria were adopted: 1) when the
S2-A2 interval exceeded the S1-A1 interval more than 50 ms on
the His bundle electrogram (33,34); 2) when the difference
between durations of A2 and A1 is exceeded by more than
70 ms on the high right atrial electrogram (35); and 3) when
two or more atrial responses with a return cycle ,300 ms
occurred (36,37). According to these criteria, 4 patients with
AVRT and 4 with AVNRT were excluded. Consequently, 21
patients with AVRT and 19 with AVNRT were enrolled in this
study.
In accordance with the previous method by Suzuki et al.
(18,22), we assessed the anterograde conduction in the con-
cealed AP in AVRT. First, the retrograde effective refractory
period of the concealed AP was measured by the right ventricle
basic drive followed by single ventricular extrastimulation
(conventional ventricular extrastimulus method). Second, the
retrograde effective refractory period of the concealed AP was
measured by the simultaneous basic drive of the right ventricle
and the high right atrium or the coronary sinus followed by
single ventricular extrastimulation (simultaneous atrioventric-
ular method). The anterograde conduction in the concealed
AP was considered to be present if the retrograde effective
refractory period obtained from the simultaneous atrioventric-
ular method was 10 ms or more shorter than that obtained
from the conventional ventricular extrastimulus method (18).
Radiofrequency catheter ablation procedure. For AVRT.
After confirming the presence of anterograde conduction in
the concealed AP, radiofrequency catheter ablation with an
electrical mapping method was performed with the retrograde
aortic approach. Briefly, a 7F deflectable tip catheter (Mans-
field, Webster Co., Watertown, Massachusetts), was intro-
duced via the femoral artery and positioned under or above the
mitral valve annulus. Radiofrequency energy (500 kHz;
NL50-1, Central Industry) was delivered through the distal
electrode at 20 watts during right ventricular pacing. When the
retrograde AP conduction was lost within 10 s, the application
of radiofrequency energy at 20 watts was maintained for 30 s.
Before and after ablation during sinus rhythm, the atrial
activity on the ablation site was recorded at a paper speed of
100 mm/s by the distal bipolar electrodes of the ablation
catheter, with a center-to-center interelectrode distance of
2 mm, using a filter bandwidth of 30 to 500 Hz (CATHCOR,
Siemens) and then the duration of the atrial activity was
measured. The duration of the atrial activity was defined as the
time from the beginning of the earliest electrical activity that
deviated from the stable baseline value to the last point of the
atrial electrogram at which the baseline value was crossed. At
30 min after the final application of radiofrequency energy, the
effects of ablation were assessed. The ablation was considered
Figure 1. Representative recordings of the P-SAECG obtained from a
normal volunteer. In the time domain analysis (panel A), the filtered
P wave duration was defined as the point at which the voltage of the
atrial signal exceeded 1 mV in the filtered P wave and returned to the
1 mV level, respectively. In the frequency domain analysis (panel B), S
and E indicates the beginning and the end of P wave, respectively. The
dark area indicates power spectrum area of 0–20 Hz zone and the
shaded area indicates power spectrum area of 20–100 Hz zone. AR20
was the power spectrum area in the 0–20 Hz zone divided by that in
the 20–100 Hz zone.
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successful if the retrograde AP conduction was no longer
present by ventricular pacing before and after administration
of both intravenous injection of atropine (1 mg, one bolus) and
intravenously continuous infusion of isoproterenol (0.02 mg/
min/kg).
For AVNRT. After the mechanism of tachycardia had been
determined to be AVNRT, radiofrequency catheter ablation
was performed with the anatomic and/or electrical mapping
approach. As described above, the same deflectable tip cathe-
ter was introduced via the femoral vein and used for ablation
of the slow pathway with a delivery of radiofrequency energy at
20 watts for 10 s. When junctional ectopic beats occurred
during the delivery of radiofrequency energy, radiofrequency
energy at 20 watts was delivered for more than 20 s. At 30 min
after the final application of radiofrequency energy, the abla-
tion procedure was considered successful if AVNRT could no
longer be induced by atrial and ventricular programmed pacing
before and after both intravenous injection of atropine and
infusion of isoproterenol.
For AT. After tachycardia was diagnosed to be automatic
AT by standard techniques (38,39), radiofrequency catheter
ablation was performed with the electrical mapping approach.
As described above, the same deflectable tip catheter was
introduced via the femoral vein and used for ablation of the
tachycardia focus with a delivery of radiofrequency energy at
20 watts for 10 s. When the tachycardia was terminated,
radiofrequency energy at 20 watts was delivered for more than
20 s. The ablation procedure was considered successful if AT
could no longer be induced by intravenous infusion of isopro-
terenol 30 min after the final application of radiofrequency
energy.
Statistical analysis. Data are presented as mean value 6
SD. Statistical differences were determined by the Student’s t
test for paired data before and after radiofrequency catheter
ablation and by the Fisher’s exact probability test for data
between groups. Multiple comparisons were examined by
repeated measures ANOVA with a post hoc Scheffe´ test. The
correlation between the changes in FPD and the duration of
atrial activity was compared by linear regression analysis. The
sensitivity, specificity and predictive accuracy were calculated
with parameters of FPD and AR20 at various cut points in
order to detect AVRT before ablation. Differences were
considered statistically significant when p was less than 0.05.
Results
Anterograde conduction in concealed AP in AVRT. The
location of all concealed APs was left-sided (left posterior area
in 5, left lateral area in 10, left anterolateral area in 5 and left
anterior area in 1). The retrograde effective refractory period
of the concealed AP obtained from the simultaneous atrioven-
tricular extrastimulus method (256 6 33 ms) was significantly
shorter than that obtained from the conventional ventricular
extrastimulus method (297 6 36 ms) in each subject. Differ-
ences in the retrograde effective refractory period of concealed
APs obtained from these two different methods were 240 6
22 ms (215 to 2110 ms), indicating the presence of antero-
grade conduction in the concealed AP in all cases of AVRT.
P-SAECG. In the time domain analysis (Fig. 2A), the FPD
in patients with AVRT was significantly longer than that in
controls and patients with AVNRT. The FPD was similar
between patients with AVRT and PAF. In the frequency
domain analysis (Fig. 2B), AR20 in patients with PAF was
significantly greater than that in other three groups. AR20 was
similar among controls, patients with AVNRT and patients
with AVRT. In patients with AVRT, FPD and AR20 in left
posterior area (n 5 5) were 132 6 4 ms and 1.7 6 0.5,
respectively; those in left lateral area (n 5 10) 130 6 9 ms and
1.9 6 0.5, respectively; those in left anterolateral area (n 5 5)
126 6 7 ms and 1.3 6 0.5, respectively; and those in left
Figure 2. Pooled data of the filtered P wave duration (panel A) by the
time domain analysis and AR20 (panel B) by the frequency domain
analysis in controls, and patients with AVNRT, AVRT or PAF.
Filtered P wave duration was significantly longer in AVRT than in
controls and AVNRT, but was similar between AVRT and PAF. AR20
was not different between in AVNRT and AVRT, but was significantly
greater in PAF than in AVRT.
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anterior area (n 5 1) 142 ms and 1.1, respectively. Statistical
analyses of FPD and AR20 among the four AP areas could not
be carried out because of the small number of patients. Figure
3 shows the representative recordings of FPD before and after
ablation in two patients of AVRT. Figure 4 shows pooled data
of FPD and AR20 before and after ablation in patients with
AVNRT, AVRT and AT. Ablation significantly shortened
FPD in patients with AVRT (from 130 6 8 to 122 6 5 ms, p ,
0.0001) but did not in patients with AVNRT and AT. Ablation
did not significantly affect AR20 in any of them. Both FPD and
AR20 after ablation were also similar among patients with
AVRT, AVNRT and AT.
In patients with AVRT, the averaged changes in FPD after
ablation by catheters placed above (n 5 8) and under (n 5 13)
the mitral valve were 9.6 6 5.2 and 7.5 6 5.1 ms, respectively.
Two different catheter ablation techniques did not differ in
terms of the averaged changes in FPD.
Duration of atrial activity at the ablation site. Figure 5
shows pooled data of the duration of atrial activity in patients
with AVRT, which were significantly shortened from 62 6 19
to 52 6 17 ms (p , 0.0001) after successful ablation. In these
patients, a total of 48 applications of radiofrequency energy
before successful ablation did not shorten the duration of atrial
activity (from 55 6 12 to 54 6 12 ms, p 5 NS). As shown in Fig.
6, there was a significant correlation between the changes in
FPD and those in the duration of atrial activity after ablation
in patients with AVRT (r 5 0.67, p , 0.001).
P wave duration on standard electrocardiogram. The
P wave durations in lead II, III, aVF and V1 were similar
among the four groups before ablation and they did not change
after ablation (Table 2).
Sensitivity and specificity for AVRT. When FPD . 125 ms
was used, the sensitivity, specificity, positive predictive accu-
racy, and negative predictive accuracy were 71%, 67%, 43%,
and 87%, respectively. When FPD . 125 ms and AR20 , 2.0
were combined, the sensitivity, specificity, positive predictive
accuracy, and negative predictive accuracy were 48%, 100%,
100%, and 85%, respectively (Table 3).
Discussion
The most important findings of the present study are: 1) the
filtered P wave duration, FPD, on P-SAECG was longer in
patients with AVRT than in patients with AVNRT or controls;
2) AR20 was significantly smaller in patients with AVRT than
in those with PAF, although FPD was similar between them; 3)
after radiofrequency catheter ablation, FPD was shortened in
patients with AVRT but not in patients with AVNRT; and 4)
the changes in FPD after ablation were correlated with those
in the duration of atrial activity obtained by electrophysiolog-
ical studies. Thus, with combined time and frequency domain
analyses we may be able to noninvasively detect anterograde
conduction in the concealed AP and to differentiate AVRT
Figure 3. Representative recordings of filtered P wave duration ob-
tained from two patients with the concealed accessory atrioventricular
pathway before and after radiofrequency catheter ablation.
59JACC Vol. 33, No. 1 YOSHIDA ET AL.
January 1999:55–62 CONCEALED LEFT ACCESSORY PATHWAY AND P-SAECG
from AVNRT. Furthermore, after successful ablation,
P-SAECG indicated the disappearance of anterograde con-
duction in the concealed AP.
Diagnosis of concealed AP. In this study, all patients with
AVRT or AVNRT had tachycardia with narrow QRS config-
urations. It is usually difficult to clinically differentiate AVRT
from AVNRT as it was in our cases. We confirmed the
diagnosis of concealed AP by the following electrophysiologi-
cal findings. First, we detected during supraventricular tachy-
cardia that the earliest retrograde atrial activation was in the
left atrial free wall in all patients with AVRT, but that was in
the low anterior septum in patients with AVNRT (10,30,31).
Second, we did not detect ventricular preexcitation (delta
wave) during decremental or premature atrial pacing (10) and
during coronary sinus pacing near the accessory pathway or by
the administration of intravenous injection of adenosine
(20 mg, one bolus) (32). Of course, the patients with AVNRT
did not have any evidence of concealed APs.
Prolonged FPD in AVRT. Concealed anterograde conduc-
tion into an accessory atrioventricular pathway is a well
demonstrated phenomenon during electrophysiological study
(16–22). In the present study, we confirmed anterograde
conduction in the concealed AP by the following electrophys-
iological findings. We determined the presence of anterograde
conduction in the concealed AP by demonstrating the peeling
back phenomenon (18). If the anterograde conduction in the
concealed AP is present, the refractoriness of the concealed
AP is peeled back by the anterograde conduction of the basic
atrial impulse during the simultaneous atrioventricular pacing,
which makes the subsequent ventricular extra impulse in the
earlier phase conduct to the atrium (18). Thus, the effective
refractory period measured by the simultaneous atrioventric-
ular pacing method becomes shorter than that measured by
conventional ventricular extrastimulus method. Suzuki et al.
(18) has reported the differences in the retrograde effective
refractory period of the concealed AP to be 251 6 30 ms
between the simultaneous atrioventricular and conventional
ventricular extrastimulus methods. Our values were 240 6
22 ms, similar to those reported by Suzuki et al. Clinical
characteristics including age, sex distribution, and other car-
diovascular diseases in this study did not differ from those in
the Suzuki’s study. Although we confirmed the anterograde
conduction of the concealed AP in our patients with AVRT by
demonstrating the peeling back phenomenon, we did not know
reasons for the small difference between the two studies. The
FPD was significantly prolonged in patients with AVRT com-
Figure 4. Pooled data of the filtered
P wave duration by the time domain
analysis and AR20 by the frequency
domain analysis before and after ra-
diofrequency catheter ablation in pa-
tients with AVNRT, AVRT and AT.
Ablation significantly shortened the
filtered P wave duration (FPD) in
AVRT but did not change in
AVNRT and AT. AR20 was not
changed in the three groups after
ablation.
Figure 5. Pooled data of the duration of atrial activity at the ablation
site in patients with AVRT. Ablation significantly shortened the
duration of atrial activity.
Figure 6. Correlation between the changes in filtered P wave duration
and those in the duration of atrial activity after radiofrequency
catheter ablation in patients with AVRT.
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pared to controls and patients with AVNRT, and there was a
clear distinction between patients with AVRT and AVNRT as
well as controls. Because no patients had organic heart disease,
and cardiac dimensions and ejection fraction were similar
among these three groups, this prolongation of FPD was not
due to organic changes of the heart, especially the left atrium.
It was not due to supraventricular tachycardia per se, because
the FPD was similar between controls and patients with
AVNRT. Thus, it is assumed that the prolonged FPD may
result from the activation potential of anterograde conduction
in the concealed AP.
To further examine this issue, we measured the duration of
atrial activity during the electrophysiological study before and
after ablation and calculated changes in the duration of atrial
activity after ablation. Successful ablation significantly short-
ened the duration of atrial activity and the FPD in patients
with AVRT, whereas unsuccessful ablation did not change the
duration of atrial activity. Accordingly, the shortening of the
duration of atrial activity was caused by the ablation of the
concealed AP but not caused by ablation per se. Furthermore,
we compared changes in the duration of atrial activity with
changes in FPD after ablation. Changes in those were signifi-
cantly correlated. Ablation of the slow pathway in AVNRT did
not alter FPD, suggesting that slow pathway conduction does
not affect FPD. One possible explanation may be due to the
difference in the structural location between left-sided APs and
slow pathways because the left-sided APs are at the epicardial
location, whereas the slow pathway is at the interior location
(3,11–14). This possibility may be also implicated for the
right-sided and septal APs which were not studied in this study.
Furthermore, the changes in FPD did not differ among abla-
tions of atrial and ventricular insertion sites. In patients with
AT, atrial ablation did not affect parameters of FPD and
AR20. Thus, the shortening of the FPD was caused by the
ablation of the concealed AP but not caused by ablation per se.
Taken together, our results suggest that the prolonged FPD in
patients with AVRT is caused by the activation of anterograde
conduction in the concealed AP.
AVRT versus PAF. In AVRT, we excluded patients with a
substrate for PAF. As shown in Fig. 2A, measurements of FPD
did not differentiate patients with AVRT from those with PAF.
The FPD was prolonged in both groups. The prolonged FPD
in patients with PAF is well known (23–27). The mean FPD in
patients with PAF was 134 6 8 ms in this study, similar to
137 6 14 ms reported by Fukunami et al. (23), 135 6 8 ms
reported by Stafford et al. (24) and 133 6 20 ms reported by us
(27). To further differentiate patients with AVRT from those
with PAF on P-SAECG, we analyzed the frequency compo-
nent of the whole P wave. We have previously demonstrated
that AR20, the power spectrum area in the 0–20 Hz zone
divided by that in the 20–100 Hz zone, was significantly greater
in patients with PAF than in controls, indicating decreased
high frequency components in PAF. In this study, AR20 was
greater in PAF than in controls as reported previously (27).
Moreover, AR20 was greater in patients with PAF than in
those with AVRT. Thus, we were able to differentiate AVRT
from PAF with AR20 even though FPD was similar between
these two groups. Although it was not the purpose of this study
to elucidate mechanisms underlying the difference of AR20
between PAF and AVRT, it is probably due to different
activations of the atrium; in PAF the activation of the whole
P wave is electrophysiologically abnormal and in AVRT only
the terminal section of the P wave may be abnormal because of
the anterograde conduction through the concealed AP.
Sensitivity and specificity. Although there was clear dis-
tinction of FPD between AVRT and AVNRT, the specificity
and positive predictive accuracy to detect AVRT was not so
high because there was a significant overlap of FPD between
AVRT and PAF. When the combination of FPD . 125 ms and
AR20 , 2.0 was used, they became 100%. Therefore, the
criteria of both FPD . 125 ms and AR20 , 2.0 have to be
fulfilled to detect AVRT when PAF was not excluded.
Limitations of the study. Several limitations of the present
study may be considered. First, we studied only left-sided APs
including free wall APs but not right-sided and septal APs.
Thus, our findings may not be directly applicable to right-sided
and septal APs. However, our findings in this study still have
clinical relevance because right-sided and septal APs are much
less frequent than left-sided APs (1,6,7,15,20). Second, we
excluded patients with a substrate for PAF according to the
exclusion criteria by electrophysiological study in this study.
Accordingly, these exclusion criteria may have excluded pa-
tients with atrial conduction abnormality in and around the
atrial insertion site of the concealed AP that may promote
Table 2. P Wave Duration on Standard Electrocardiogram
Control
(n 5 20)
AVNRT
(n 5 19)
AVRT (n 5 21)
PAF
(n 5 22)Before After
Lead II (ms) 101 6 9 98 6 6 101 6 6 100 6 7 103 6 12
Lead III (ms) 101 6 11 95 6 8 98 6 5 97 6 5 102 6 10
Lead aVF (ms) 102 6 8 97 6 8 99 6 4 99 6 4 100 6 15
Lead V1 (ms) 100 6 11 95 6 7 98 6 13 97 6 11 96 6 10
Data are presented mean value 6 SD. Abbreviations are as same as shown
in Table 1.
Table 3. Sensitivity, Specificity and Predictive Accuracy of
P-SAECG for AVRT
Sensitivity
(%)
Specificity
(%)
Positive
Predictive
Accuracy (%)
Negative
Predictive
Accuracy (%)
FPD . 120 ms 86 39 33 89
FPD . 125 ms 71 67 43 87
FPD . 130 ms 52 79 46 83
FPD . 125 ms and
AR20 , 2.0
48 100 100 85
FPD . 125 ms and
AR20 , 2.5
67 90 70 89
FPD . 125 ms and
AR20 , 3.0
71 80 56 89
FPD 5 filtered P wave duration; AR20 5 power spectrum area ratio of 0–20
to 20–100 Hz.
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PAF. This may have resulted in the decrease in the number of
patients with AVRT and limited the clinical use of the
P-SAECG. In this regard, a prospective study with the
P-SAECG is necessary for the differential diagnosis of parox-
ysmal supraventricular tachycardia in patients in whom PAF
was not excluded. Finally, we confirmed anterograde conduc-
tion in the concealed AP by the Suzuki et al. method. The
results obtained from this method may represent the peeling
back of accessory pathway refractoriness or that of atrial
refractoriness, although it is unlikely to be able to differentiate
them.
Conclusions. The present study, to the best of our knowl-
edge, provides the first demonstration that P-SAECG using the
combination of time and frequency domain analyses is nonin-
vasively capable of detecting the anterograde conduction in
concealed AP and useful for differentiating AVRT from
AVNRT during sinus rhythm. Thus, P-SAECG may provide
the validity as a research and clinical tool to accurately describe
atrial activation patterns.
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